UPDATE 3-Novartis copy of Amgen arthritis drug highly similar -FDA staff

July 11 (Reuters) - Novartis AG's cheaper version

of Amgen Inc's blockbuster arthritis drug Enbrel is

highly similar in potency and safety to the original, according

to a review by Food and Drug...

Read more